Addressing Knowledge Gaps in Acute Myeloid Leukemia to Improve Referral for Hematopoietic Cell Transplantation Consultation
نویسندگان
چکیده
منابع مشابه
Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that are considered investigational or cosmetic. Providers may bill members for services or procedures that are considered investigational or cosmetic. Providers are encouraged to inform members before rendering such services that the members are likely to be financially responsible for the cost of these se...
متن کاملHematopoietic Cell Transplantation for Acute Myeloid Leukemia
Patient Selection Criteria Coverage eligibility will be considered for allogeneic hematopoietic cell transplant (allo-HCT) using a myeloablative conditioning (MAC) regimen to treat acute myeloid leukemia (AML) when ANY of the following criteria are met: Poorto intermediaterisk acute myeloid leukemia (AML) in first complete remission (CR1) (see Policy Guidelines section for information on risk...
متن کاملPreliminary Results of Allogenic Hematopoietic Stem Cell Transplantation of non-M3 Acute Myeloid Leukemia
Background: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is used as treatment of choice for patients with acute myeloid leukemia (AML). We aimed to evaluate the prognostic factors in 2-year overall survival of patients with non-M3 AML who underwent allogenic HSCT. Methods: This is a Cross sectional retrospective study. Demographic data and study of variables such as age...
متن کامل150 Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
Poorto intermediate-risk acute myeloid leukemia (AML) in remission AML that is refractory to standard induction chemotherapy but can be brought into CR with intensified induction chemotherapy AML that relapses following chemotherapy-induced CR1 but can be brought into CR2 or beyond with intensified induction chemotherapy; or AML in patients, who have relapsed following a prior autologou...
متن کاملHematopoietic stem cell transplantation for acute myeloid leukemia.
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) yields a high rate of curability for acute myeloid leukemia (AML), it is also associated with transplant-related morbidity and mortality (TRM). The risk and severity of TRM increase with the use of an alternative donor graft in the absence of an HLA-matched sibling donor (MSD). With the declining birthrate and aging of the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the National Comprehensive Cancer Network
سال: 2019
ISSN: 1540-1405,1540-1413
DOI: 10.6004/jnccn.2019.7327